A new RNA ecosystem is emerging. With the high-speed development of mRNA vaccines, brought on by rapid advances in the broader area of RNA biology and therapeutics, RNA products are being developed for a wide array of needs. From cancer treatments, to diagnostics, to agriculture, RNA science may hold the key to understanding some of the most complex conditions.
The Institute links and expands multidisciplinary teams in RNA biology, RNA chemistry and RNA medicine, with clinical experts and services, underpinned by a pilot-scale RNA accelerator facility.
The formation of a dedicated Institute for RNA science, therapeutics and translational support is timely and will help ensure that NSW becomes a major international hub in the RNA ecosystem, positioned to make critical contributions to major advances in human health.
The institute will have at its centre the ‘RNA Production Accelerator’, a facility for scaling-up and producing promising RNA and nanoparticle drug candidates at pilot-scale before having them fast-tracked for pre-clinical trials. The UNSW RNA Institute, together with its partners, are building a world-leading manufacturing capability in NSW that will yield jobs, skills, and innovation in an industry with the potential to transform lives.